The meeting has the category of a classic educational activity where many people come to teach, to learn, and also to discuss the value of how standard as well as new approaches are being incorporated into the management of ovarian cancer. In this symposium, held in one day, we cover all hot topics concerning diagnosis, biology and therapy of ovarian cancer.
This is a two-day international scientific program that aims to provide state-of-the-art information on breast cancer, achieving a balance of clinical, translational, and basic research, and to provide a forum for exchange, communication, and education for medical oncologists, gynecologists and other specialists with a special interest in breast cancer.
Cancer rates across the Middle East are expected to double between 2012 and 2030, according to World Health Organisation (WHO) estimates—the highest relative increase of any region globally. This rise is caused by a combination of environmental factors, lifestyle choices and increasing detection rates, but it is further driven by limited access to high-quality treatment and care. How can a holistic, affordable and sustainable system provide care for all?
Building on global dialogues at War on Cancer events in Europe, Latin America and Asia, War on Cancer: Middle East 2019 will advance the conversation by bringing together policymakers, industry leaders, health-care providers, insurers, investors, scientists, technologists and prominent thinkers to explore how a cancer-care pathway should be designed, funded and implemented across the Middle East. What needs to be done to improve prevention, screening, early detection and treatment, and how can policymakers and regulators educate the region’s population about healthy lifestyle choices? How can stakeholders ensure that care is not just for the wealthy, but accessible to all members of society?
The War on Cancer Asia Summit is part of our global initiative to catalyse fresh debate and drive progress in cancer control. The event will gather a diverse audience from the medical, practitioner, and provider communities, together with policymakers, patients, advocates, NGOs and civil society. We will examine the state of play of National Cancer Control Plans across Asia, explore best practices and areas for improvement, and create a manifesto for accelerated action and change.
Patient groups are beginning to emerge across Asia, and patient advocacy is starting to find its voice. Against the backdrop of a rising cancer burden and increasing demand for quality care, the summit will aim to accelerate the pace of patient advocacy across the region to drive better care and policy. We will draw on case studies showing effective collaboration among patient groups, and between these groups and policymakers. The summit will explore where working together has transformed policies and practices in prevention, early detection, treatment and care. We will also examine the potential pitfalls as we place these examples in the regional context.
A mantra on the role of advocacy in modern health care systems asserts: “No decision about me, without me.” Our mission is to create a workable vision that points the way towards making this mantra a reality for cancer care in Asia. Join us and add your support.
2019 ASCO Annual Meeting
Caring for Every Patient, Learning from Every Patient | #ASCO19
The 2019 International Cancer Screening Network (ICSN) Conference will take place in Rotterdam, the Netherlands. The meeting is jointly organized by the department of Public Health at the Erasmus MC University Medical Center Rotterdam in the Netherlands and the Center for Global Health at the U.S. National Cancer Institute (NCI).
The theme of this year’s conference will be “Screening in Balance”, emphasizing the importance of continuously weighing the benefits and harms of cancer screening programs. The focus of the conference will be on collaborative research that fosters efficient and effective approaches to cancer control worldwide through organized approaches to population-based cancer screening.
Meeting topics will include, but are not limited to:
Novel strategies in Screening & BIG DATA
Cancer screening in low and middle income countries
Lung cancer screening
Controversial issues in screening (e.g. treatment effects, false positives, and overtreatment)
Impact of screening policies and strategies
Communicating screening in balance (engaging patients and professionals)
Reaching the hard-to-reach populations
The meeting will be open to cancer screening research across all cancer sites, for which population-based screening is being delivered, piloted or seriously considered.
European Cancer Care: across boarders.
ESMO 2019 annual Congress will take place in partnership with the European Association for Cancer Research (EACR).
The African Organisation for Research and Training in Cancer’s 12th International Conference on Cancer in Africa: